biopharmaceutical – Thought Leader Select

Triangle Business Journal Selects Meade for Guest Column

In the wake of the Sunshine Act’s Open Payments database launch, press detailing payments made to doctors by the pharma and medical device industries is fueling speculation about the negative impact this development could have on industry. Given the Raleigh-Durham area’s top medical centers and concentration of pharmaceutical/device manufacturers, the release of this information could …

Triangle Business Journal Selects Meade for Guest Column Read More »

Meade Featured as Sunshine Disclosure Expert

Uncategorized / By bcastle

As disclosures of life science industry payments to healthcare professionals continue with rollouts such as the Centers for Medicare and Medicaid Services’ Open Payments Database in late September, Thought Leader Select’s Paul Meade has been a sought-after expert on the impact of these disclosures on industry collaborations with key opinion leaders in medicine. Meade, the …

Meade Featured as Sunshine Disclosure Expert Read More »

Thought Leader Select Customizes KOL Identification Methodologies in Support of Global Diabetes Initiatives

Uncategorized / By bcastle

By Brian Castle Throughout most of 2014, Thought Leader Select has been privileged to work with a top-five global biopharmaceutical giant in support of its diabetes portfolio in across the globe. For this particular engagement, across several countries with cultural and language differences, stakeholders within the client company needed a customized approach. The chosen approach …

Thought Leader Select Customizes KOL Identification Methodologies in Support of Global Diabetes Initiatives Read More »

Thought Leader Select Sponsors Canadian Healthcare Licensing Association Summer Meeting

Uncategorized / By bcastle

Thought Leader Select sponsored last week’s summer meeting of a leading North American life sciences trade group, the Canadian Healthcare Licensing Association (CHLA). The CHLA’s summer meeting took place June 4-6 at the Queen’s Landing Resort in Niagara-on-the-Lake, Ontario, bringing together dozens of leaders in marketing, reimbursement, and business development from leading global biopharmaceutical firms …

Thought Leader Select Sponsors Canadian Healthcare Licensing Association Summer Meeting Read More »

Biopharma Tabs Thought Leader Select for KOL, Centers of Excellence Strategies in Atrial Fibrillation

Uncategorized / By bcastle

April 24, 2014 (CHAPEL HILL, NC) Thought Leader Select, a research and consulting firm serving the life sciences industries, recently earned a new engagement supporting a top-10 global biopharmaceutical company’s efforts in the area of atrial fibrillation and stroke prevention. The client company, known worldwide as a leader in the development of prescription medicines and nutrition …

Biopharma Tabs Thought Leader Select for KOL, Centers of Excellence Strategies in Atrial Fibrillation Read More »

Medical Affairs: Find the Missing KOLs

Uncategorized / By bcastle

By Brian Castle Thought Leader Select is a company dedicated to one purpose: helping companies in the life sciences to optimize their relationships with key opinion leaders in medicine. Biopharmaceutical, device, and diagnostics companies work with thought leaders in particular therapeutic areas and diseases as they develop and manufacture new treatment solutions for patients. It’s …

Medical Affairs: Find the Missing KOLs Read More »

US Biopharma Chooses Thought Leader Select for KOL Initiatives in Lupus

Uncategorized / By bcastle

December 4, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, is working with a U.S. biopharmaceutical company on key opinion leader (KOL) initiatives in systemic lupus. The client company, a leader in developing new medicines for difficult-to-treat auto-immune and inflammatory disorders, chose North Carolina’s Thought Leader Select to assist …

US Biopharma Chooses Thought Leader Select for KOL Initiatives in Lupus Read More »

Global Biopharma Continues Work with Thought Leader Select for KOL Initiatives in COPD

Uncategorized / By bcastle

October 3, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned new work in developing key opinion leader (KOL) strategies in support of new treatments for chronic obstructive pulmonary disorder (COPD) for a top global biopharmaceutical concern. The client company, one of the world’s top ten industry leaders …

Global Biopharma Continues Work with Thought Leader Select for KOL Initiatives in COPD Read More »

Biopharma Giant Tabs Thought Leader Select for Initiatives in Companion Diagnostics for Oncology Products

Uncategorized / By bcastle

July 9, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader has chosen Thought Leader Select to perform critical research and advisory work in support of key opinion leader initiatives advancing companion diagnostics for oncology medications. Thought Leader Select, headquartered in Chapel Hill, North Carolina, provides research and consulting services to companies in the life sciences industry, …

Biopharma Giant Tabs Thought Leader Select for Initiatives in Companion Diagnostics for Oncology Products Read More »

Global Pharmas Choose Thought Leader Select as Vendor of Choice for KOL Initiatives

Uncategorized / By bcastle

(CHAPEL HILL, NC) Canadian subsidiaries of a pair of top-15 global biopharmaceutical companies have appointed Thought Leader Select as their preferred research and engagement advisor for key opinion leader initiatives in multiple therapeutic areas. Thought Leader Select, headquartered in Chapel Hill, North Carolina, provides research and advisory services to companies in the life sciences industry, including …

Global Pharmas Choose Thought Leader Select as Vendor of Choice for KOL Initiatives Read More »